Spring Bank Pharmaceuticals, Inc. (SBPH)
(Delayed Data from NSDQ)
$7.05 USD
+0.16 (2.32%)
Updated May 3, 2019 04:00 PM ET
After-Market: $6.94 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[SBPH]
Reports for Purchase
Showing records 1 - 17 ( 17 total )
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Unclassified
Q2/17 shows Progress in HBV, Oncology programs
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: WASSERMAN R
Industry: Unclassified
Industry: Unclassified
Industry: Unclassified
DSMB Gives Go-Ahead to Next ACHIEVE Trial Cohort
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: GRISEWOOD S
Industry: Unclassified
Industry: Unclassified
Industry: Unclassified
Industry: Unclassified
Industry: Unclassified
Spring Bank is a clinical stage biotech company developing immune and inflammatory modulating small-chain nucleotide-based pharmaceuticals.
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: GRISEWOOD S
Industry: Unclassified
Industry: Unclassified
Industry: Unclassified
Focus on Nucleotide-based Therapy Positive
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: GRISEWOOD S
Industry: Unclassified
Pipeline Technology Featured in Upcoming AACR Meeting
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: GRISEWOOD S
Industry: Unclassified
Industry: Unclassified
A Busy Week for SBPH is Topped Off with Insider Buying
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: GRISEWOOD S
|